🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
TLL018 is developed for treatment of autoimmune and inflammatory diseases i...
Status
Completed
Location
Frontage Clinical Services, Inc.
Start Date
2020-01-26
Trial ID
NCT04243083
Treatments Being Tested
This is a Phase I, single-center trial to assess the safety, tolerability, ...
Status
Recruiting
Location
Huashan Hospital, Fudan University
Start Date
2026-02-05
Trial ID
NCT07409922
Treatments Being Tested
A PHASE 1, RANDOMIZED, PLACEBO CONTROLLED, MULTIPLE ASCENDING DOSE (MAD) ST...
Status
Completed
Location
Altasciences
Start Date
2023-01-06
Trial ID
NCT06025396
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of sin...
Status
Completed
Location
PRA Health Sciences
Start Date
2015-09-15
Trial ID
NCT02742779
This is a phase 1, first-in-human, randomized, double-blind, placebo-contro...
Status
Completed
Location
Scientia Clinical Research Ltd
Start Date
2021-09-27
Trial ID
NCT05112159
A first-in-human study to evaluate the safety, tolerability, pharmacokineti...
Status
Completed
Location
Scientia Clinical Research
Start Date
2024-05-21
Trial ID
NCT06787131
Treatments Being Tested
This study will assess the safety, tolerability, and pharmacokinetics (PK) ...
Status
Completed
Location
Quotient Sciences
Start Date
2020-04-27
Trial ID
NCT04672499
Treatments Being Tested
"This study is a single-center, randomized, double-blinded and placebo-cont...
Status
Completed
Location
Huashan Hospital, Fudan University
Start Date
2018-03-19
Trial ID
NCT03458650
Treatments Being Tested
Part 1 of the study will be conducted to provide additional information on ...
Status
Completed
Location
Quotient Sciences
Start Date
2018-03-21
Trial ID
NCT03464058
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multipl...
Status
Active Not Recruiting
Location
Medpace Clinical Pharmacology
Start Date
2025-10-23
Trial ID
NCT07223216
Treatments Being Tested